Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 773M | 764M | 716M | 664M |
Cost of revenue | 449M | 432M | 409M | 387M |
Gross profit | 324M | 332M | 307M | 277M |
Operating expense | ||||
Research & development | 121M | 93M | 97M | 104M |
Selling general and admin | 195M | 235M | 194M | 209M |
Other operating expenses | -8M | -5M | -6M | -2M |
Operating income | 16M | 9M | 22M | -34M |
Non operating interest income | ||||
Income | 72M | 45M | 81M | 46M |
Expense | 5M | -14M | — | 31M |
Other income expense | -59M | -57M | -56M | -32M |
Pretax income | 24M | 11M | 47M | -51M |
Tax provision | 14M | 0 | 32M | 18M |
Net income | 10M | 11M | 15M | -69M |
Basic EPS | — | 0.0 | 0.0 | 0.0 |
Diluted EPS | — | 0.0 | 0.0 | 0.0 |
Basic average shares | — | 4.0B | 4.0B | 4.0B |
Diluted average shares | — | 4.2B | 4.3B | 4.0B |
EBITDA | 127M | 125M | 74M | 47M |
Net income from continuing op. | 24M | 11M | 47M | -51M |
Minority interests | 14M | 15M | 11M | 16M |
Preferred stock dividends | — | — | — | — |